PALI
PALISADE BIO, INC.
+0.05 (+2.66%)1.74USD2.3M成交股數302M市值2.7本益比(近四季)604.7股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 6 · 250K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 410K · 2 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 250K · 410K |
| 近 180 天 淨額 | −160K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | 08-21 | Finley John David | CEO, CFO | G 贈與 | 88.4K | – | – | 129K | SEC |
| 2026-08-19 | 08-21 | Finley John David | CEO, CFO | G 贈與 | 88.4K | – | – | 88.5K | SEC |
| 2026-07-09 | 07-10 | Baltera Robert Jr. | Director | P 公開市場買進 | 25.0K | 1.96 | 49K | 462K | SEC |
| 2026-07-08 | 07-10 | Baltera Robert Jr. | Director | P 公開市場買進 | 20.0K | 1.99 | 40K | 437K | SEC |
| 2026-07-07 | 07-08 | Finley John David | CEO, CFO | S 公開市場賣出 | 147K | 2.07 | 303K | 218K | SEC |
| 2026-07-07 | 07-08 | Finley John David | CEO, CFO | M 選擇權執行 | 133 | 0.70 | 93.10 | 218K | SEC |
| 2026-07-07 | 07-08 | Jones Mitchell Lawrence | Chief Medical Officer | S 公開市場賣出 | 51.9K | 2.05 | 107K | 94.0K | SEC |
| 2026-07-07 | 07-08 | Baltera Robert Jr. | Director | P 公開市場買進 | 30.0K | 2.03 | 61K | 417K | SEC |
| 2026-07-06 | 07-08 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 131K | – | – | 146K | SEC |
| 2026-07-06 | 07-08 | Baltera Robert Jr. | Director | P 公開市場買進 | 20.0K | 2.05 | 41K | 387K | SEC |
| 2026-07-06 | 07-08 | Finley John David | CEO, CFO | M 選擇權執行 | 335K | – | – | 364K | SEC |
| 2026-07-02 | 07-06 | Baltera Robert Jr. | Director | P 公開市場買進 | 10.0K | 1.98 | 20K | 367K | SEC |
| 2026-07-01 | 07-06 | Baltera Robert Jr. | Director | P 公開市場買進 | 20.0K | 1.98 | 40K | 357K | SEC |
| 2026-06-10 | 06-18 | Baltera Robert Jr. | Director | A 獲配股票 | 337K | – | – | 337K | SEC |
| 2026-06-10 | 06-12 | Wei Binxian | Director | A 獲配股票 | 592K | – | – | 593K | SEC |
| 2026-06-10 | 06-12 | Chuang Emil | Director | A 獲配股票 | 592K | – | – | 592K | SEC |
| 2026-06-10 | 06-12 | Zwick Jordan Michael | Director | A 獲配股票 | 337K | – | – | 337K | SEC |
| 2026-06-10 | 06-12 | Williams Donald Allen | Director | M 選擇權執行 | 60.7K | – | – | 1.6M | SEC |
| 2026-06-10 | 06-12 | Williams Donald Allen | Director | A 獲配股票 | 1.5M | – | – | 1.5M | SEC |
| 2026-06-10 | 06-12 | Wei Binxian | Director | M 選擇權執行 | 20.2K | – | – | 613K | SEC |
| 2026-06-10 | 06-12 | Chuang Emil | Director | M 選擇權執行 | 20.2K | – | – | 613K | SEC |
| 2026-02-12 | 02-13 | Jones Mitchell Lawrence | Chief Medical Officer | S 公開市場賣出 | 2.0K | 1.75 | 3K | 13.3K | SEC |
| 2026-02-12 | 02-13 | Finley John David | CEO, CFO | S 公開市場賣出 | 3.9K | 1.75 | 7K | 27.4K | SEC |
| 2026-02-11 | 02-13 | Finley John David | CEO, CFO | M 選擇權執行 | 13.3K | – | – | 31.2K | SEC |
| 2026-02-11 | 02-13 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 8.0K | – | – | 15.3K | SEC |
| 2026-01-16 | 01-21 | Williams Donald Allen | Director | P 公開市場買進 | 5.0K | 1.67 | 8K | 10.7K | SEC |
| 2026-01-09 | 01-13 | Williams Donald Allen | Director | P 公開市場買進 | 5.0K | 1.88 | 9K | 5.7K | SEC |
| 2024-11-21 | 11-22 | Wei Binxian | Director | M 選擇權執行 | 388 | – | – | 855 | SEC |
| 2024-11-21 | 11-22 | Williams Donald Allen | Director | M 選擇權執行 | 388 | – | – | 728 | SEC |
| 2024-06-11 | 06-12 | Wei Binxian | Director | M 選擇權執行 | 465 | – | – | 467 | SEC |
| 2024-06-11 | 06-12 | Williams Donald Allen | Director | M 選擇權執行 | 340 | – | – | 340 | SEC |
| 2024-05-28 | 05-30 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 1.6K | – | – | 10.1K | SEC |
| 2024-05-28 | 05-30 | Jones Mitchell Lawrence | Chief Medical Officer | F 繳稅扣股 | 461 | 4.76 | 2K | 3.9K | SEC |
| 2024-05-28 | 05-30 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 1.6K | – | – | 4.3K | SEC |
| 2024-05-28 | 05-30 | Finley John David | CEO, CFO, Director | F 繳稅扣股 | 467 | 4.76 | 2K | 9.6K | SEC |
| 2024-05-28 | 05-30 | Jones Mitchell Lawrence | Chief Medical Officer | F 繳稅扣股 | 810 | 4.76 | 4K | 2.8K | SEC |
| 2024-05-28 | 05-30 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 2.7K | – | – | 3.6K | SEC |
| 2024-05-28 | 05-30 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 2.1K | – | – | 14.1K | SEC |
| 2024-05-28 | 05-30 | Finley John David | CEO, CFO, Director | F 繳稅扣股 | 607 | 4.76 | 3K | 13.5K | SEC |
| 2024-05-28 | 05-30 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 3.3K | – | – | 12.9K | SEC |
| 2024-05-28 | 05-30 | Finley John David | CEO, CFO, Director | F 繳稅扣股 | 959 | 4.76 | 5K | 12.0K | SEC |
| 2024-05-28 | 05-29 | Williams Donald Allen | Director | P 公開市場買進 | 1.0K | 4.86 | 5K | 1.0K | SEC |
| 2024-05-24 | 05-28 | Finley John David | CEO, CFO, Director | P 公開市場買進 | 1.0K | 4.81 | 5K | 8.4K | SEC |
| 2024-05-20 | 05-22 | Finley John David | CEO, CFO, Director | A 獲配股票 | 666 | 4.97 | 3K | 7.4K | SEC |
| 2024-05-06 | 05-08 | Finley John David | CEO, CFO, Director | F 繳稅扣股 | 61 | 8.46 | 516.06 | 6.8K | SEC |
| 2024-05-06 | 05-08 | Jones Mitchell Lawrence | CEO, CFO, Director | F 繳稅扣股 | 47 | 8.46 | 397.62 | 833 | SEC |
| 2024-05-06 | 05-08 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 232 | – | – | 6.7K | SEC |
| 2024-05-06 | 05-08 | Jones Mitchell Lawrence | CEO, CFO, Director | M 選擇權執行 | 156 | – | – | 880 | SEC |
| 2024-05-06 | 05-08 | Jones Mitchell Lawrence | CEO, CFO, Director | F 繳稅扣股 | 90 | 8.46 | 761.40 | 724 | SEC |
| 2024-05-06 | 05-08 | Jones Mitchell Lawrence | CEO, CFO, Director | M 選擇權執行 | 304 | – | – | 814 | SEC |
| 2024-05-06 | 05-08 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 211 | – | – | 6.8K | SEC |
| 2024-05-06 | 05-08 | Finley John David | CEO, CFO, Director | F 繳稅扣股 | 67 | 8.46 | 566.82 | 6.6K | SEC |
| 2024-03-11 | 03-12 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 5.6K | – | – | 96.8K | SEC |
| 2024-02-09 | 02-13 | Neal James R | Director | M 選擇權執行 | 5.8K | – | – | 10.9K | SEC |
| 2024-02-09 | 02-13 | Neal James R | Director | M 選擇權執行 | 5.1K | – | – | 5.1K | SEC |
| 2024-02-08 | 02-13 | Diaz Stephanie | Director | M 選擇權執行 | 7.0K | – | – | 7.0K | SEC |
| 2024-02-08 | 02-13 | Trenschel Robert J. | Director | M 選擇權執行 | 5.8K | – | – | 10.9K | SEC |
| 2024-02-08 | 02-13 | Csimma Cristina | Director | M 選擇權執行 | 5.8K | – | – | 12.9K | SEC |
| 2024-02-08 | 02-13 | Diaz Stephanie | Director | M 選擇權執行 | 5.8K | – | – | 12.8K | SEC |
| 2024-02-08 | 02-13 | Csimma Cristina | Director | M 選擇權執行 | 7.0K | – | – | 7.0K | SEC |
| 2024-02-08 | 02-13 | Trenschel Robert J. | Director | M 選擇權執行 | 5.1K | – | – | 5.1K | SEC |
| 2024-02-06 | 02-08 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 3.2K | – | – | 91.3K | SEC |
| 2024-02-06 | 02-08 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 4.6K | – | – | 7.5K | SEC |
| 2024-02-06 | 02-08 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 3.5K | – | – | 88.1K | SEC |
| 2024-02-06 | 02-08 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 2.3K | – | – | 9.8K | SEC |
| 2024-02-06 | 02-08 | Jones Mitchell Lawrence | Chief Medical Officer | F 繳稅扣股 | 2.2K | 0.44 | 947.32 | 7.7K | SEC |
| 2024-02-06 | 02-07 | Finley John David | CEO, CFO, Director | P 公開市場買進 | 10.0K | 0.47 | 5K | 84.6K | SEC |
| 2024-01-31 | 02-01 | Williams Donald Allen | Director | P 公開市場買進 | 10.0K | 0.61 | 6K | 30.0K | SEC |
| 2024-01-31 | 02-01 | Finley John David | CEO, CFO, Director | P 公開市場買進 | 10.0K | 0.56 | 6K | 74.6K | SEC |
| 2024-01-03 | 01-05 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 1.3K | – | – | 64.6K | SEC |
| 2023-12-11 | 12-19 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 5.6K | – | – | 63.3K | SEC |
| 2023-11-20 | 11-24 | Finley John David | CEO, CFO, Director | A 獲配股票 | 10.0K | 0.51 | 5K | 57.8K | SEC |
| 2023-11-07 | 11-08 | Jones Mitchell Lawrence | Chief Medical Officer | F 繳稅扣股 | 1.6K | 0.54 | 880.20 | 2.9K | SEC |
| 2023-11-06 | 11-08 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 3.5K | – | – | 47.8K | SEC |
| 2023-11-06 | 11-08 | Jones Mitchell Lawrence | Chief Medical Officer | M 選擇權執行 | 4.6K | – | – | 4.6K | SEC |
| 2023-10-04 | 10-05 | Finley John David | CEO, CFO, Director | F 繳稅扣股 | 397 | 0.55 | 218.35 | 44.3K | SEC |
| 2023-10-03 | 10-05 | Finley John David | CEO, CFO, Director | M 選擇權執行 | 1.3K | – | – | 44.7K | SEC |
| 2023-09-27 | 09-29 | Williams Donald Allen | Director | P 公開市場買進 | 20.0K | 0.54 | 11K | 20.0K | SEC |
| 2023-09-27 | 09-29 | Finley John David | CEO, CFO, Director | P 公開市場買進 | 15.0K | 0.54 | 8K | 43.4K | SEC |
| 2023-09-14 | 09-15 | Trenschel Robert J. | Director | S 公開市場賣出 | 300 | 0.64 | 192.00 | 0 | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | 13.1M | 27.3M | 新進 | 新進 |
| B Group, Inc. | 11.4M | 23.9M | 不變 | 持平 |
| AMERIPRISE FINANCIAL INC | 11.1M | 23.2M | −429K (-4%) | 減碼 |
| Jupiter Topco LLC | 10.7M | 22.4M | 新進 | 新進 |
| BlackRock, Inc. | 10.4M | 21.8M | +8.6M (+456%) | 加碼 |
| Octagon Capital Advisors LP | 10.3M | 21.5M | 不變 | 持平 |
| PERCEPTIVE ADVISORS LLC | 8.4M | 17.6M | −503K (-6%) | 減碼 |
| RA CAPITAL MANAGEMENT, L.P. | 7.1M | 14.9M | 不變 | 持平 |
| FRANKLIN RESOURCES INC | 5.8M | 12.1M | 不變 | 持平 |
| Point72(柯恩) Point72 Asset Management, L.P. | 5.3M | 11.0M | +4.8M (+1176%) | 加碼 |
| Boxer Capital Management, LLC | 4.8M | 10.0M | 不變 | 持平 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.5M | 9.4M | 不變 | 持平 |
| Eversept Partners, LP | 4.2M | 8.7M | −805K (-16%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.8M | 7.9M | +2.2M (+143%) | 加碼 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.7M | 7.7M | +799K (+28%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 3.6M | 7.5M | −1.8M (-33%) | 減碼 |
| FEDERATED HERMES, INC. | 3.1M | 6.6M | 不變 | 持平 |
| Squadron Capital Management LLC | 3.0M | 6.3M | 不變 | 持平 |
| Propel Bio Management, LLC | 2.6M | 5.4M | +1.5M (+132%) | 加碼 |
| Vestal Point Capital, LP | 2.5M | 5.2M | 不變 | 持平 |
| STATE STREET CORP | 2.5M | 5.2M | +1.8M (+289%) | 加碼 |
| MORGAN STANLEY | 2.5M | 5.2M | −2.1M (-46%) | 減碼 |
| ORBIMED ADVISORS LLC | 2.3M | 4.9M | 不變 | 持平 |
| GREAT POINT PARTNERS LLC | 2.3M | 4.8M | −1.1M (-33%) | 減碼 |
| SPHERA FUNDS MANAGEMENT LTD. | 2.3M | 4.7M | +524K (+30%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 124 +28 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 50 / 22 / 32 / 24 |
| 機構合計持股 · 佔流通股 | 173M · 99.5% |
| 合計季末市值 | 362M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 30.9M |
|---|---|
| 與上期比 | -7.5% |
| 佔流通股數 | 17.73% |
| 日均成交量 | 1.6M |
| 回補天數 | 19.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 30.9M | -7.5% | 17.73% | 1.6M | 19.1 |
| 2026-08-14 | 33.4M | -0.9% | 19.16% | 1.5M | 22.0 |
| 2026-07-31 | 33.7M | -9.0% | 19.34% | 2.3M | 14.6 |
| 2026-07-15 | 37.0M | +15.2% | 21.24% | 3.7M | 10.0 |
| 2026-06-30 | 32.1M | +1.9% | 18.44% | 6.0M | 5.4 |
| 2026-06-15 | 31.5M | +2.3% | 18.09% | 2.6M | 11.9 |
| 2026-05-29 | 30.8M | +14.4% | 17.68% | 2.9M | 10.8 |
| 2026-05-15 | 26.9M | +3.0% | 15.45% | 2.6M | 10.4 |
| 2026-04-30 | 26.1M | +2.0% | 15.00% | 5.0M | 5.2 |
| 2026-04-15 | 25.6M | -0.5% | 14.71% | 3.7M | 7.0 |
| 2026-03-31 | 25.8M | -1.5% | 14.79% | 4.7M | 5.4 |
| 2026-03-13 | 26.2M | -2.2% | 15.01% | 3.0M | 8.8 |
| 2026-02-27 | 26.7M | +5.5% | 15.34% | 3.0M | 8.8 |
| 2026-02-13 | 25.4M | +20.2% | 14.55% | 3.2M | 8.0 |
| 2026-01-30 | 21.1M | +20.6% | 12.10% | 6.0M | 3.5 |
| 2026-01-15 | 17.5M | +9.7% | 10.04% | 5.8M | 3.0 |
| 2025-12-31 | 15.9M | +24.4% | 9.15% | 5.6M | 2.8 |
| 2025-12-15 | 12.8M | -8.3% | 7.36% | 5.7M | 2.2 |
| 2025-11-28 | 14.0M | +75.9% | 8.02% | 3.7M | 3.8 |
| 2025-11-14 | 7.9M | +4.6% | 4.56% | 3.7M | 2.2 |
| 2025-10-31 | 7.6M | +28.3% | 4.36% | 4.9M | 1.5 |
| 2025-10-15 | 5.9M | +470.5% | 3.40% | 30.8M | 1.0 |
| 2025-09-30 | 1.0M | +108.7% | 0.60% | 1.7M | 1.0 |
| 2025-09-15 | 497K | +48.4% | 0.29% | 795K | 1.0 |
| 2025-08-29 | 335K | -21.0% | 0.19% | 284K | 1.2 |
| 2025-08-15 | 424K | +26.4% | 0.24% | 9.3M | 1.0 |